166 related articles for article (PubMed ID: 17341023)
1. Design and X-ray crystal structures of human thrombin with synthetic cyanopeptide-analogues.
Radau G; Fokkens J
Pharmazie; 2007 Feb; 62(2):83-8. PubMed ID: 17341023
[TBL] [Abstract][Full Text] [Related]
2. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
3. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
4. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW
Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244
[TBL] [Abstract][Full Text] [Related]
5. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
[TBL] [Abstract][Full Text] [Related]
6. New cyanopeptide-derived low molecular weight thrombin inhibitors.
Radau G; Gebel J; Rauh D
Arch Pharm (Weinheim); 2003 Aug; 336(8):372-80. PubMed ID: 14502757
[TBL] [Abstract][Full Text] [Related]
7. Cyanopeptide analogues: new lead structures for the design and synthesis of new thrombin inhibitors.
Radau G; Stürzebecher J
Pharmazie; 2002 Nov; 57(11):729-32. PubMed ID: 12611274
[TBL] [Abstract][Full Text] [Related]
8. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
[TBL] [Abstract][Full Text] [Related]
9. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
[TBL] [Abstract][Full Text] [Related]
10. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template.
Jhoti H; Cleasby A; Reid S; Thomas PJ; Weir M; Wonacott A
Biochemistry; 1999 Jun; 38(25):7969-77. PubMed ID: 10387040
[TBL] [Abstract][Full Text] [Related]
12. Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.
Sperl S; Bergner A; Stürzebecher J; Magdolen V; Bode W; Moroder L
Biol Chem; 2000 Apr; 381(4):321-9. PubMed ID: 10839461
[TBL] [Abstract][Full Text] [Related]
13. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
Katz BA; Luong C
J Mol Biol; 1999 Sep; 292(3):669-84. PubMed ID: 10497030
[TBL] [Abstract][Full Text] [Related]
14. Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition.
Dullweber F; Stubbs MT; Musil D; Stürzebecher J; Klebe G
J Mol Biol; 2001 Oct; 313(3):593-614. PubMed ID: 11676542
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
Chirgadze NY; Sall DJ; Klimkowski VJ; Clawson DK; Briggs SL; Hermann R; Smith GF; Gifford-Moore DS; Wery JP
Protein Sci; 1997 Jul; 6(7):1412-7. PubMed ID: 9232642
[TBL] [Abstract][Full Text] [Related]
16. New cyanopeptide-derived low molecular weight inhibitors of trypsin-like serine proteases.
Radau G; Schermuly S; Fritsche A
Arch Pharm (Weinheim); 2003 Aug; 336(6-7):300-9. PubMed ID: 12953218
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation.
Dumas JJ; Kumar R; Seehra J; Somers WS; Mosyak L
Science; 2003 Jul; 301(5630):222-6. PubMed ID: 12855811
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models.
Bertrand JA; Oleksyszyn J; Kam CM; Boduszek B; Presnell S; Plaskon RR; Suddath FL; Powers JC; Williams LD
Biochemistry; 1996 Mar; 35(10):3147-55. PubMed ID: 8605148
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and SAR of thrombin inhibitors incorporating a novel 4-amino-morpholinone sscaffold: analysis of X-ray crystal structure of enzyme inhibitor complex.
Nilsson JW; Kvarnström I; Musil D; Nilsson I; Samulesson B
J Med Chem; 2003 Sep; 46(19):3985-4001. PubMed ID: 12954052
[TBL] [Abstract][Full Text] [Related]
20. Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies.
De Simone G; Menchise V; Omaggio S; Pedone C; Scozzafava A; Supuran CT
Biochemistry; 2003 Aug; 42(30):9013-21. PubMed ID: 12885234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
